T1	CHEM 1 18	Metilprednisolona
#1	AnnotatorNotes T1	C0025815; methylprednisolone; Organic Chemical · Hormone · Pharmacologic Substance
T2	PROC 44 65	bypass cardiopulmonar
#2	AnnotatorNotes T2	C0007202; Cardiopulmonary Bypass; Therapeutic or Preventive Procedure
T3	ANAT 51 65	cardiopulmonar
#3	AnnotatorNotes T3	C0553534; Cardiopulmonary; Body Location or Region
T4	ANAT 827 835	cardíaca
#4	AnnotatorNotes T4	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T5	PROC 81 112	estudio doble ciego randomizado
#5	AnnotatorNotes T5	C0013072; Double-Blind Method; Research Activity + C0034656; Randomization; Research Activity
T6	DISO 1239 1269	infección bacteriana o fúngica
#6	AnnotatorNotes T6	C0004623; Bacterial Infections; Disease or Syndrome | C0026946; Mycoses; Disease or Syndrome
T7	PROC 131 152	bypass cardiopulmonar
#7	AnnotatorNotes T7	C0007202; Cardiopulmonary Bypass; Therapeutic or Preventive Procedure
T8	ANAT 138 152	cardiopulmonar
#8	AnnotatorNotes T8	C0553534; Cardiopulmonary; Body Location or Region
T9	PROC 157 182	circulación extracorpórea
#9	AnnotatorNotes T9	C0015354; Extracorporeal Circulation; Therapeutic or Preventive Procedure
T10	DISO 198 242	síndrome de respuesta inflamatoria sistémica
#10	AnnotatorNotes T10	C0242966; Systemic Inflammatory Response Syndrome; Disease or Syndrome
T11	CHEM 313 324	corticoides
#11	AnnotatorNotes T11	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T13	PROC 435 451	cirugía cardíaca
#12	AnnotatorNotes T13	C0018821; Cardiac Surgery procedures; Therapeutic or Preventive Procedure
T14	ANAT 443 451	cardíaca
#13	AnnotatorNotes T14	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T15	CHEM 512 522	esteroides
#14	AnnotatorNotes T15	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T16	PROC 567 599	cirugía de bypass cardiopulmonar
T17	PROC 1426 1460	analizadas por intención de tratar
#15	AnnotatorNotes T17	C2718028; Intention to Treat Analysis; Research Activity
T18	ANAT 585 599	cardiopulmonar
#16	AnnotatorNotes T18	C0553534; Cardiopulmonary; Body Location or Region
T19	PROC 663 707	ensayo randomizado, controlado y doble ciego
#17	AnnotatorNotes T19	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T20	PROC 819 835	cirugía cardíaca
#18	AnnotatorNotes T20	C0018821; Cardiac Surgery procedures; Therapeutic or Preventive Procedure
T21	PROC 862 895	cirugía con bypass cardiopulmonar
T22	ANAT 881 895	cardiopulmonar
#19	AnnotatorNotes T22	C0553534; Cardiopulmonary; Body Location or Region
T23	CHEM 910 927	metilprednisolona
#20	AnnotatorNotes T23	C0025815; methylprednisolone; Organic Chemical · Hormone · Pharmacologic Substance
T24	PROC 940 960	inducción anestésica
#21	AnnotatorNotes T24	C0853212; Induction of anesthesia; Therapeutic or Preventive Procedure
T25	PROC 987 993	bypass
#22	AnnotatorNotes T25	C0741847; Bypass; Therapeutic or Preventive Procedure
T26	PROC 997 1004	placebo
#23	AnnotatorNotes T26	C0032042; Placebos; Therapeutic or Preventive Procedure
T27	CHEM 1050 1061	corticoides
#24	AnnotatorNotes T27	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T28	PROC 1113 1151	tratamiento con corticoides sistémicos
T29	PROC 1295 1302	cirugía
#25	AnnotatorNotes T29	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T30	DISO 1402 1412	enfermedad
#26	AnnotatorNotes T30	C0012634; Disease; Disease or Syndrome
T31	CHEM 1522 1539	metilprednisolona
#27	AnnotatorNotes T31	C0025815; methylprednisolone; Organic Chemical · Hormone · Pharmacologic Substance
T32	PROC 1552 1559	placebo
#28	AnnotatorNotes T32	C0032042; Placebos; Therapeutic or Preventive Procedure
T33	CHEM 1638 1655	metilprednisolona
#29	AnnotatorNotes T33	C0025815; methylprednisolone; Organic Chemical · Hormone · Pharmacologic Substance
T34	PROC 1670 1677	placebo
#30	AnnotatorNotes T34	C0032042; Placebos; Therapeutic or Preventive Procedure
T35	CHEM 1825 1842	metilprednisolona
#31	AnnotatorNotes T35	C0025815; methylprednisolone; Organic Chemical · Hormone · Pharmacologic Substance
T36	PROC 1868 1889	bypass cardiopulmonar
#32	AnnotatorNotes T36	C0007202; Cardiopulmonary Bypass; Therapeutic or Preventive Procedure
T37	ANAT 1875 1889	cardiopulmonar
#33	AnnotatorNotes T37	C0553534; Cardiopulmonary; Body Location or Region
T38	CHEM 1129 1140	corticoides
#34	AnnotatorNotes T38	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T39	DISO 1701 1707	muerte
#35	AnnotatorNotes T39	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T40	DISO 1741 1750	patología
#36	AnnotatorNotes T40	C0677042; Pathology processes; Pathologic Function
T41	LIVB 22 31	pacientes
#37	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	Date 293 307	postoperatoria
#38	AnnotatorNotes T42	C0032790; Postoperative Period; Temporal Concept
T44	LIVB 398 422	pacientes de alto riesgo
#39	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group + C0870646; High Risk Populations; Population Group
T45	LIVB 530 554	pacientes de alto riesgo
#40	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group + C0870646; High Risk Populations; Population Group
T46	LIVB 732 757	pacientes con alto riesgo
#41	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group + C0870646; High Risk Populations; Population Group
T48	Dose 929 935	250 mg
T49	Dose 963 969	250 mg
T50	Neg_cue 1006 1017	Se excluyen
T51	LIVB 1024 1033	pacientes
#42	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Duration 1071 1078	crónica
#43	AnnotatorNotes T52	C0205191; chronic; Temporal Concept
T53	Date 1158 1172	postoperatorio
#44	AnnotatorNotes T53	C0032790; Postoperative Period; Temporal Concept
T54	Neg_cue 1184 1195	Se excluyen
T55	LIVB 1209 1218	pacientes
#45	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	LIVB 1262 1269	fúngica
#46	AnnotatorNotes T56	C0016832; Fungi; Fungus
T57	Duration 1270 1281	los 30 días
T58	Duration 1355 1366	los 30 días
T59	LIVB 1501 1510	pacientes
#47	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T61	Date 1581 1600	21 de junio de 2007
T63	Date 1610 1633	19 de diciembre de 2013
T65	Spec_cue 1691 1700	riesgo de
T66	Duration 1710 1721	los 30 días
T69	LIVB 1846 1855	pacientes
#48	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T71	LIVB 1249 1259	bacteriana
#49	AnnotatorNotes T71	C0004611; Bacteria; Bacterium
T70	DISO 339 361	respuesta inflamatoria
#50	AnnotatorNotes T70	C1155266; Inflammatory Response; Pathologic Function
T43	Neg_cue 325 333	suprimen
T12	PROC 1561 1571	reclutados
#51	AnnotatorNotes T12	C0242800; Patient Recruitment; Research Activity
A1	Assertion T70 Negated
A2	Assertion T51 Negated
A3	Assertion T28 Negated
A4	Assertion T27 Negated
A5	Assertion T55 Negated
A6	Assertion T6 Negated
A7	Assertion T39 Speculated
A9	Assertion T38 Negated
A8	Status T6 History_of
R1	Experiences Arg1:T41 Arg2:T1	
R2	Experiences Arg1:T41 Arg2:T2	
R3	Location_of Arg1:T3 Arg2:T2	
R4	Location_of Arg1:T8 Arg2:T7	
R5	Combined_with Arg1:T7 Arg2:T9	
R6	Causes Arg1:T7 Arg2:T10	
T47	Observation 277 292	morbimortalidad
R7	Overlap Arg1:T47 Arg2:T42	
R8	Overlap Arg1:T10 Arg2:T47	
R9	Negation Arg1:T43 Arg2:T70	
T60	Spec_cue 364 371	podrían
T62	Observation 372 379	mejorar
A10	Assertion T62 Speculated
#52	AnnotatorNotes T62	C0184511; Improved; Finding (?)
R11	Speculation Arg1:T60 Arg2:T62	
R12	Before Arg1:T11 Arg2:T62	
R13	Experiences Arg1:T44 Arg2:T70	
R14	Experiences Arg1:T44 Arg2:T11	
R15	Experiences Arg1:T44 Arg2:T13	
R16	Location_of Arg1:T14 Arg2:T13	
R17	Experiences Arg1:T44 Arg2:T62	
R18	Experiences Arg1:T45 Arg2:T15	
R19	Experiences Arg1:T45 Arg2:T16	
R20	Location_of Arg1:T18 Arg2:T16	
#53	AnnotatorNotes T16	C0007202; Cardiopulmonary Bypass; Therapeutic or Preventive Procedure
T64	Observation 761 776	morbimortalidad
R21	Experiences Arg1:T46 Arg2:T64	
R22	Location_of Arg1:T4 Arg2:T20	
R23	Experiences Arg1:T46 Arg2:T20	
R24	Location_of Arg1:T22 Arg2:T21	
R25	Experiences Arg1:T46 Arg2:T21	
#54	AnnotatorNotes T21	C0007202; Cardiopulmonary Bypass; Therapeutic or Preventive Procedure
R26	Experiences Arg1:T46 Arg2:T23	
R27	Has_Dose_or_Strength Arg1:T23 Arg2:T48	
R28	Used_for Arg1:T23 Arg2:T24	
R29	Has_Dose_or_Strength Arg1:T23 Arg2:T49	
R31	Experiences Arg1:T46 Arg2:T24	
R32	Experiences Arg1:T46 Arg2:T25	
R33	Experiences Arg1:T46 Arg2:T26	
R34	Before Arg1:T24 Arg2:T25	
R35	Before Arg1:T24 Arg2:T21	
R36	Before Arg1:T24 Arg2:T20	
R37	Causes Arg1:T20 Arg2:T64	
R38	Causes Arg1:T21 Arg2:T64	
R39	Causes Arg1:T25 Arg2:T64	
R40	Negation Arg1:T50 Arg2:T51	
R41	Negation Arg1:T50 Arg2:T27	
R42	Has_Duration_or_Interval Arg1:T27 Arg2:T52	
R43	Experiences Arg1:T51 Arg2:T28	
R44	Negation Arg1:T50 Arg2:T28	
R45	Negation Arg1:T50 Arg2:T38	
R46	Used_for Arg1:T38 Arg2:T28	
R47	Overlap Arg1:T28 Arg2:T53	
R49	Negation Arg1:T54 Arg2:T55	
R50	Negation Arg1:T54 Arg2:T6	
R51	Causes Arg1:T71 Arg2:T6	
R52	Causes Arg1:T56 Arg2:T6	
R53	Has_Duration_or_Interval Arg1:T6 Arg2:T57	
R54	Before Arg1:T6 Arg2:T29	
R55	Experiences Arg1:T55 Arg2:T6	
R56	Experiences Arg1:T55 Arg2:T29	
T68	Observation 1034 1078	consumidores de corticoides de forma crónica
R57	Experiences Arg1:T51 Arg2:T68	
T72	CONC 1342 1352	mortalidad
#56	AnnotatorNotes T72	C0026565; Mortality Vital Statistics; Quantitative Concept
R58	Overlap Arg1:T72 Arg2:T58	
T73	CONC 1387 1397	mortalidad
R59	Overlap Arg1:T73 Arg2:T30	
T74	Quantifier_or_Qualifier 1413 1418	grave
#57	AnnotatorNotes T74	C1547227; Severe - Severity of Illness Code; Intellectual Product
R60	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T74	
R61	Experiences Arg1:T59 Arg2:T31	
R62	Experiences Arg1:T59 Arg2:T32	
R63	After Arg1:T12 Arg2:T61	
R64	Before Arg1:T12 Arg2:T63	
T75	Quantifier_or_Qualifier 1751 1756	grave
#58	AnnotatorNotes T75	C1547227; Severe - Severity of Illness Code; Intellectual Product
R65	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T75	
R66	Speculation Arg1:T65 Arg2:T39	
T76	Neg_cue 1678 1680	no
T77	CONC 1681 1687	reduce
#59	AnnotatorNotes T77	C0547047; Decrease; Quantitative Concept
R67	Negation Arg1:T76 Arg2:T77	
A11	Assertion T77 Negated
R68	Overlap Arg1:T39 Arg2:T66	
T78	CONC 1728 1738	mortalidad
T79	Neg_cue 1791 1793	no
T80	CONC 1794 1804	recomienda
A12	Assertion T80 Negated
#60	AnnotatorNotes T80	C0034866; Recommendation; Idea or Concept
R69	Negation Arg1:T79 Arg2:T80	
R70	Experiences Arg1:T69 Arg2:T35	
T81	Quantifier_or_Qualifier 1812 1821	rutinario
R71	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T81	
A13	Assertion T81 Negated
R72	Negation Arg1:T79 Arg2:T81	
R73	Experiences Arg1:T69 Arg2:T36	
R74	Location_of Arg1:T37 Arg2:T36	
R77	Overlap Arg1:T20 Arg2:T23	
R79	Before Arg1:T33 Arg2:T39	
R80	Before Arg1:T34 Arg2:T39	
#61	AnnotatorNotes T78	C0026565; Mortality Vital Statistics; Quantitative Concept
R81	Before Arg1:T33 Arg2:T40	
T83	Spec_cue 746 757	alto riesgo
A14	Assertion T64 Speculated
R83	Speculation Arg1:T83 Arg2:T64	
T84	Observation 543 554	alto riesgo
#63	AnnotatorNotes T84	C4319571; High risk; Finding
R84	Experiences Arg1:T45 Arg2:T84	
T85	Observation 411 422	alto riesgo
#64	AnnotatorNotes T85	C4319571; High risk; Finding
R85	Experiences Arg1:T44 Arg2:T85	
T67	Observation 497 504	efectos
#55	AnnotatorNotes T67	C1518681; Outcome of Therapy; Finding (?)
R10	Causes Arg1:T15 Arg2:T67	
R48	Overlap Arg1:T23 Arg2:T82	
R75	Overlap Arg1:T25 Arg2:T26	
T82	CONC 974 993	comienzo del bypass
#62	AnnotatorNotes T73	C0026565; Mortality Vital Statistics; Quantitative Concept
R30	Before Arg1:T34 Arg2:T77	
R76	Before Arg1:T33 Arg2:T77	
R78	Has_Dose_or_Strength Arg1:T26 Arg2:T49	
R82	Has_Dose_or_Strength Arg1:T26 Arg2:T48	
#65	AnnotatorNotes T81	C0205547; Routine; Qualitative Concept
#66	AnnotatorNotes T28	C4053960; Systemic Corticosteroid Therapy; Therapeutic or Preventive Procedure
A15	Experiencer T41 Patient
A16	Experiencer T44 Patient
A17	Experiencer T45 Patient
A18	Experiencer T46 Patient
A19	Experiencer T51 Patient
A20	Experiencer T55 Patient
A21	Experiencer T59 Patient
A22	Experiencer T69 Patient
A23	Status T28 Future
A24	Status T38 Future
